Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation THKKF


Primary Symbol: V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Feb 13, 2023 9:00am
515 Views
Post# 35282738

Important line from todays new release

Important line from todays new release"Combined with our earlier announcement, we have been able to secure approximately $5.5 million of incremental revenue this week across multiple services and solutions and the sales pipeline continues to grow."

I suspect the addition of "sales pipeline continues to grow", which is a big and significant statement to make, suggests that there are other wins or expansion of existing clients that the company is either in final stages of negotiating and/or has won but due to confidentiality agreements can't press release.

Assuming at least a modest recovery in the overall stock market - IMO THNK will be somewhere between $1.50 to $2.00 by end of year. Given their capital needs there is likely limited additional dilution of shares that will occur and an eventual unwind of the balance sheet debt is naturally around the corner.
<< Previous
Bullboard Posts
Next >>